ABEONA THERAPEUTICS INC (ABEO) Stock Cash Flow
NASDAQ:ABEO - Nasdaq - US00289Y2063 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.73M | -54.19M | -39.70M | -84.94M | -84.23M | |||
| Depreciation Amortization | 2.91M | 3.20M | 3.09M | 3.25M | 4.59M | |||
| Change In Working Capital | -4.38M | -1.79M | -5.89M | -18.26M | 1.63M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | 7.00K | N/A | N/A | 0.00 | N/A | |||
| Other non cash items | 9.20M | 15.77M | -990.00K | 34.28M | 43.00M | |||
| OPERATING CASH FLOW | -56.02M | -37.01M | -43.48M | -65.67M | -35.02M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.45M | -331.00K | -130.00K | -4.15M | -1.34M | |||
| Other Investing Activity | -36.79M | 539.00K | -23.83M | 70.21M | -82.38M | |||
| INVESTING CASH FLOW | -39.24M | 208.00K | -23.96M | 66.06M | -83.71M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 20.00M | N/A | N/A | 0.00 | 1.76M | |||
| Stock Issued/Repurchased | 85.10M | 37.21M | 43.17M | 24.86M | 180.00K | |||
| Other Financing Activity | -963.00K | -150.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 104.14M | 37.06M | 43.17M | 24.86M | 1.94M | |||
| CHANGE IN CASH | 8.88M | 256.00K | -24.27M | 25.25M | -116.79M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -56.02M | -37.01M | -43.48M | -65.67M | -35.02M | |||
| Capital Expenditure | -2.45M | -331.00K | -130.00K | -4.15M | -1.34M | |||
| FREE CASH FLOW | -58.46M | -37.34M | -43.61M | -69.82M | -36.36M | |||
All data in USD